Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
Cellebrite DI Ltd. Ordinary Shares (CLBT) is trading at $13.59 as of the latest session, marking a 0.37% decline from its previous closing price. This analysis outlines key market context, technical support and resistance levels, and potential near-term price action scenarios for investors monitoring the stock. No recent earnings data is available for CLBT as of the date of publication, so price action in recent weeks has been driven primarily by broader market sentiment and sector-specific tren
Why Cellebrite (CLBT) could be the anchor your portfolio needs (Underperforming) 2026-05-05 - Small Cap Breakout
CLBT - Stock Analysis
4157 Comments
720 Likes
1
Ayako
Power User
2 hours ago
Someone get a slow clap going… 🐢👏
👍 88
Reply
2
Tasheona
Legendary User
5 hours ago
Volume is concentrated in certain sectors, reflecting shifting investor priorities.
👍 273
Reply
3
Jadalyse
Senior Contributor
1 day ago
Free US stock portfolio rebalancing tools and asset allocation optimization for maintaining your target investment mix over time. We help you maintain proper diversification and risk exposure through automated rebalancing recommendations and drift alerts. Our platform provides tax-loss harvesting suggestions and portfolio drift analysis for comprehensive portfolio management. Maintain optimal portfolio allocation with our comprehensive rebalancing tools and asset optimization strategies for long-term success.
👍 290
Reply
4
Cordarius
Senior Contributor
1 day ago
Trading volume supports a healthy market environment.
👍 37
Reply
5
Tashana
Senior Contributor
2 days ago
I was literally searching for this… yesterday.
👍 185
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.